Medspa Treatment Pricing Benchmarks (National & Regional)

Botox Cosmetic (onabotulinumtoxinA) remains the category anchor. National average pricing ranges from $12–$16 per unit for established practices; premium urban markets (Manhattan, Miami, Los Angeles) command $16–$20+, while secondary and tertiary markets often sit at $10–$13. Dysport (abobotulinumtoxinA), which diffuses more widely, is typically priced $4–$6 per unit (roughly 2.5–3× the Botox unit count for equivalent effect, so per-treatment cost converges). Xeomin (incobotulinumtoxinA), marketed as the "naked" toxin, usually prices at $12–$16 per unit, often matching Botox. Daxxify (daxibotulinumtoxinA), the longest-acting option (up to 6 months claimed), commands a premium: $18–$24 per unit, reflecting both novelty and the extended interval between treatments. Evolus Jeuveau (prabotulinumtoxinA), the newest entrant, typically prices at $10–$14 per unit to gain share. Glabellar lines average 20–25 units; crow's feet 12–16 units per side; forehead 10–15 units. A full-face treatment thus ranges from $250–$600 depending on toxin choice and market. Regional variation is sharp: Tier-1 metros (NYC, SF, Miami, LA) run 30–40% higher than Tier-2 (Austin, Denver, Nashville) and 50%+ higher than rural/secondary markets.

Hyaluronic acid (HA) fillers dominate by volume. Juvéderm Ultra XC/Plus and Restylane Lyft/Silk (the category workhorses) price at $600–$900 per syringe nationally; premium markets reach $1,000–$1,400. Juvéderm Voluma (for cheek/chin augmentation) runs $700–$1,100. RHA Redensity (Revance's dynamic HA), newly FDA-cleared for undereye hollowing, prices at $700–$1,000 per syringe, positioning as a premium HA. Radiesse (calcium hydroxylapatite, CaHA), a biostimulator, typically costs $700–$1,050 per syringe; its longer duration (12–18 months vs. 6–12 for HA) justifies the premium. Sculptra (poly-L-lactic acid, PLLA), the original volumizer, requires 2–3 vials per treatment at $800–$1,200 per vial; total cost per treatment $1,600–$3,600. Bellafill (PMMA microspheres + collagen), permanent, prices at $900–$1,300 per syringe but commands a permanence premium. Lips average 1–2 syringes ($600–$1,800); cheeks 2–3 ($1,200–$2,700); tear troughs 0.5–1 ($300–$900). Tier-1 markets run 25–35% above national average; Tier-2 markets 10–15% below.

Microneedling (RF and traditional) ranges widely by technology. Traditional microneedling (SkinPen, Bellus3D) runs $300–$600 per session; RF microneedling (Morpheus8, Secret RF, Infini) commands $600–$1,200 per treatment due to energy-device overhead and provider training. Packages of 3–4 sessions often discount to $1,500–$3,000 total. Chemical peels (VI Peel, TCA, glycolic) price at $150–$400 per session depending on depth and brand; VI Peel Precision Plus typically $250–$350. Hydrafacial (non-invasive vortex fusion) runs $150–$300 per session; packages of 4–6 often $500–$1,200. Laser skin resurfacing (ablative CO₂, fractional) costs $1,500–$4,000+ per session; non-ablative fractional laser $800–$2,000. Regional variation is moderate (15–25%) because these treatments are less luxury-positioned than injectables; secondary markets price within 10–20% of Tier-1 centers.

Ultrasound therapy (Ultherapy PRIME, Ultherapy) prices at $1,500–$3,000 per full-face treatment; regional variation is modest (10–20%). Radiofrequency skin tightening (Thermage, Profound RF) runs $2,000–$4,500 depending on area and depth; Thermage FLX typically $2,500–$3,500. Laser hair removal (Candela, Lumenis, Alma) averages $200–$400 per session for small areas (underarms, bikini); full legs $600–$1,200. Packages of 6–8 sessions often discount to $1,200–$4,000 total. IPL photorejuvenation (Lumenis M22, Cutera Xeo) runs $300–$600 per session for face/neck. Laser tattoo removal (Quanta, Candela) costs $150–$500 per session per tattoo, highly variable by size and ink. Tier-1 markets command 20–30% premiums on device-based treatments due to higher capital amortization and provider expertise; Tier-2 markets often 15–20% below national average.

Tier-1 metros (NYC, Los Angeles, Miami, San Francisco, Chicago) price 30–50% above national average across all categories. A $12/unit Botox becomes $16–$18; a $800 syringe filler becomes $1,000–$1,200. Tier-2 cities (Austin, Denver, Nashville, Charlotte, Phoenix) typically run 5–15% above national average. Tier-3 and rural markets price 10–30% below national average. Concierge and luxury-positioned practices (high-end medical spas, plastic surgeon offices in affluent zip codes) add 20–40% premiums across the board. Medically-supervised chains and DSOs often price 10–20% below independent practices in the same market, leveraging volume purchasing and standardized protocols. Patient demographics matter: practices serving high-net-worth clientele in coastal metros sustain premium pricing; practices in price-sensitive suburban and rural markets must compete on value. Provider credentials also move pricing: board-certified dermatologists and plastic surgeons command 15–25% premiums over nurse injectors and aestheticians in the same market, though this gap is narrowing in competitive markets.

Cost of goods (toxin, filler, needles, anesthetic) typically represents 15–25% of treatment revenue for injectables; energy devices run 5–15% (after amortization). A $800 filler syringe costs the practice $120–$160 wholesale (depending on volume tier and loyalty program rebates via Alle, Aspire, or Evolus Rewards); a $12/unit Botox costs roughly $1–$1.50 per unit at volume. Provider labor (injector time, training, liability) is the largest variable cost: a nurse injector earning $60–$80K salary + benefits costs roughly $35–$45/hour fully loaded; a 30-minute treatment at $600 (2 syringes) yields ~$300 gross margin after COGS, leaving $150–$200 for overhead, rent, and profit. Overhead (rent, utilities, staff, compliance, insurance) typically runs 30–50% of revenue; practices in high-rent markets must price higher or operate at lower margins. Breakeven patient volume for a single injector: assume $2,000/week revenue target, $800/week COGS (40%), $600/week labor, $400/week overhead = $1,800 cost. At $600 average treatment, you need ~3–4 treatments/week to breakeven; 6–8/week yields modest profit. Practices that underprice relative to local market and COGS often discover they cannot sustain quality staff or invest in new equipment.

Average transaction value (ATV) per patient visit is your north-star metric. Track it by treatment type, provider, and month. Practices in Tier-1 markets should target $800–$1,200 ATV; Tier-2 $600–$900; Tier-3 $400–$700. Blended unit price (total revenue ÷ total units of toxin sold) reveals whether you're competing on volume or margin. If your Botox blended price is $10/unit in a $14 market, you're leaving money on the table or targeting a different patient segment. Treatment mix (% revenue from injectables vs. devices vs. skincare) affects profitability: injectables yield higher margins but lower frequency; devices build loyalty and recurring revenue. Repeat rate (% of patients returning within 12 months) is more important than per-visit price; a $500 treatment with 80% annual repeat rate outperforms a $700 treatment with 40% repeat. Acquisition cost (marketing spend ÷ new patients) should not exceed 20–30% of ATV; if you're spending $200 to acquire a patient with $600 ATV, you need them to return 2–3 times to profit. Use your EMR and accounting software to segment pricing by payer type (cash, membership, insurance), geography of patient residence, and referral source; this reveals which segments are most profitable and sustainable.